Wynhoven B's Publications

"Dynamic Range" of Inferred Phenotypic HIV Drug Resistance Values in Clinical Practice
2011 | PLoS One | Swenson L
Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and "deep" sequencing to plasma RNA and proviral DNA
2010 | J Acquir Immune Defic Syndr | Swenson L
Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection
2010 | Clinical Infectious Diseases | Gill V
Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to AZT through both RNase H dependent and independent mechanisms.
2008 | The Journal of Biological Chemistry | Ehteshami M
Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency
2008 | AIDS | Harrigan PR
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide
2007 | Antiviral Research | Loutfy M
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors
2007 | Infections, Genetics and Evolution | Deforche K
Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy
2007 | Journal of Infectious Diseases | Brumme ZL
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance
2007 | PLoS Medicine | Yap S
Prevalence and clinical implications of insertions in the HIV-1 p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapy
2007 | Antiviral Therapy | Brumme ZL